Paul V. Maier, Director at MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX), bought 5,000 shares at $2.30 ($12K) on 2015-05-29, disclosed to the SEC on 2015-06-02.
Open-market purchase of $12k MBVX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ETON | BUY | 2018-11-15 | $30K | — | Filing → |
| MBVX | SELL | 2018-01-24 | $30K | — | Filing → |
| SQNM | BUY | 2012-08-02 | $27K | — | Filing → |